Pyxis Oncology to Participate in Two Upcoming Investor Conferences
BOSTON, May 14, 2025 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer and Chief Medical Officer, will ...
Highland Copper Announces Completion of Copperwood Metallurgical Drilling and Continued Progress on Detailed Engineering
VANCOUVER, British Columbia, May 14, 2025 ( GLOBE NEWSWIRE ) -- Highland Copper Company Inc. ( TSXV: HI. OTCQB: HDRSF ) ( "Highland" or the "Company" ) is pleased to provide an update on recent developments at its 100%-owned Copperwood Project ( "Copperwood" ) and the White Pine North Project ( ...
Plus Therapeutics' REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases ( LM )
Multiple long-term LM survivors in those patients receiving multiple doses of ...
nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call
WILMINGTON, N.C., May 14, 2025 ( GLOBE NEWSWIRE ) -- nCino, Inc. ( NASDAQ: NCNO ) , the leading provider of intelligent, best-in-class banking solutions, will report financial results for its first quarter ended April 30, 2025, after the market close on Wednesday, May 28, 2025. nCino will host a ...
Highland Copper Announces Completion of Copperwood Metallurgical Drilling and Continued Progress on Detailed Engineering - Highland Copper Co ( OTC:HDRSF )
VANCOUVER, British Columbia, May 14, 2025 ( GLOBE NEWSWIRE ) -- Highland Copper Company Inc. HIHDRSF ( "Highland" or the "Company" ) is pleased to provide an update on recent developments at its 100%-owned Copperwood Project ( "Copperwood" ) and the White Pine North Project ( "White Pine" ) , a ...
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - Pyxis Oncology ( NASDAQ:PYXS )
BOSTON, May 14, 2025 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. PYXS, a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, today announced that Lara S.
Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
First Biomarker Analysis from Phase 1b Study of GT-02287 in Parkinson's Disease Expected Mid-2025 First Biomarker Analysis from Phase 1b Study of GT-02287 in Parkinson's Disease Expected ...
nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call - Ncino ( NASDAQ:NCNO )
WILMINGTON, N.C., May 14, 2025 ( GLOBE NEWSWIRE ) -- nCino, Inc. NCNO, the leading provider of intelligent, best-in-class banking solutions, will report financial results for its first quarter ended April 30, 2025, after the market close on Wednesday, May 28, 2025. nCino will host a conference ...
Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update
Imdusiran combination therapy has functionally cured 8 patients with chronic hepatitis B ( cHBV ) to date, including 2 patients who received no interferon ...
